乳房假体取出666例:假体周围感染的抗生素治疗与预防
该回顾性研究分析2012—2017年431例患者共666次乳房假体取出或更换的微生物数据,发现63个假体培养出细菌,凝固酶阴性葡萄球菌多见于无临床感染征象者,金黄色葡萄球菌多见于有临床感染者,所有病原体对万古霉素敏感。
要点
- 晚期包膜挛缩与拭子培养阳性比例较高相关(p<0.05)。
- 无临床感染征象的拭子中11.5%存在细菌污染。
- 头孢呋辛和阿莫西林/克拉维酸可用于预防与治疗,万古霉素为重症及晚期包膜挛缩置换预防首选。
核心结论
- 细菌污染多为偶然发现,在晚期包膜挛缩时更常见。
- 凝固酶阴性葡萄球菌是无临床感染征象时的优势病原体,金黄色葡萄球菌是有临床感染证据时的优势病原体。
- 所有病原体对万古霉素敏感。
研究设计与样本
- 单中心回顾性研究,评估2012年1月1日至2017年12月31日所有假体更换或取出患者。
- 共431例患者、666次假体取出或更换。
- 291例患者(449个假体)采集微生物涂片。
主要发现
- 63个假体(56例患者)培养出细菌。
- 晚期包膜挛缩与拭子阳性比例较高相关(p<0.05)。
- 11.5%的拭子在无临床感染征象时发现细菌污染。
关键数值与推荐
- 头孢呋辛和阿莫西林/克拉维酸被证明是预防和治疗假体周围感染的合理选择。
- 万古霉素成为暴发性感染治疗及晚期包膜挛缩假体置换预防的首选。
- 所有病原体对万古霉素敏感。
临床怎么用
- 根据临床感染征象区分经验性抗生素选择:无征象时考虑凝固酶阴性葡萄球菌,有征象时考虑金黄色葡萄球菌。
- 晚期包膜挛缩假体置换预防及暴发性感染治疗可选用万古霉素。
- 常规预防与一线治疗可选用头孢呋辛或阿莫西林/克拉维酸。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Periprosthetic infections are feared complications in esthetic and reconstructive breast surgery. The purpose of our study is to evaluate our institution's specific culture data and to identify most common organisms and suitable antibiotics for prophylaxis and first-line treatment. We evaluated all patients with a change or removal of breast implants from 01.01.2012 to 31.12.2017 retrospectively. Based on the medical records, the surgical indications were identified and specifically analyzed for signs of infection, reasons for primary and secondary surgery, and all available microbiological data of these interventions. A total of 666 implant removals or exchanges were performed in 431 patients. Microbiological smears were gathered from 291 patients (449 implants). Bacteria were cultured from 63 implants (56 patients). In six additional patients (ten implants), a periprosthetic infection was seen, without bacteria detection. Advanced capsular contracture correlated with a higher proportion of positive swabs (p<0.05). In 11.5% of smears, bacterial contamination was found despite absence of clinical signs of infection. Coagulase-negative staphylococci were the dominant pathogen in clinical inapparent infections, while Staphylococcus aureus was when there was clinical evidence of infection. All pathogens were sensitive to vancomycin. In the majority of cases, bacterial contamination was an incidental finding, which was more common in the presence of advanced capsular contracture. In our institution, cefuroxime and amoxicillin/clavulanic acid have been proven to be reasonable choices for prevention and treatment of periprosthetic infections. In the treatment of fulminant infections and for the prophylaxis during implant replacement due to advanced capsular contracture, vancomycin became our first choice.
引用
- Lohmeyer JA, Jakob VL, Keck M, et al. Antibiotic treatment and prophylaxis of periprosthetic infections: Evaluation of 666 consecutive breast implant removals. J Plast Reconstr Aesthet Surg. 2020. PMID: 33308989. doi:10.1016/j.bjps.2020.11.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。